Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Categories: Pharma

India’s Drugmakers Squeezed by China

Posted by: Bruce Einhorn on November 03

With the cost of manufacturing in China going up and companies stung by an endless series of Made-in-China scandals, lots of corporate executives talk about a China-plus-one strategy. Yes, you...

India drug scare = U.S. protectionism?

Posted by: Bruce Einhorn on September 23

According to the Economic Times, there are Indians wondering about what the U.S. is really up to by banning the import of 30 drugs by Ranbaxy. The FDA announced the...

Ranbaxy Calls Rudy Giuliani for Help

Posted by: Bruce Einhorn on September 18

We’ve been covering the ongoing problems that Indian drugmaker Ranbaxy has been having with the FDA in the U.S. Now, just days after the FDA announced a ban on the...

Indian Pharma Ranbaxy Slammed by FDA

Posted by: Bruce Einhorn on September 17

Drug companies hoping to outsource production to low-cost locations in India are probably following closely the news about Ranbaxy Laboratories, arguably India's premier drugmaker and a big seller of generic...

Ranbaxy in hot water with US FDA

Posted by: Frederik Balfour on July 15

Here is a blog from my colleague Nandini Lakshman in India: Talk about unfortunate timing. Barely a month after Ranbaxy Laboratories, India's largest drug maker, entered into a landmark deal...

For Indian Pharma, a Demoralizing Ranbaxy Deal

Posted by: Bruce Einhorn on June 12

The news that Japan's Daiichi Sankyo has acquired Ranbaxy, the leading Indian drugmaker, is a major blow to India's pharmaceutical ambitions. For many boosters of India’s pharma industry, it’s a...

A New Indian Challenge to Big Pharma

Posted by: Bruce Einhorn on February 29

Just when Thailand shows signs of backing down in its confrontation with global drugmakers, Big Pharma may be facing an even bigger Asian challenge, this time in India. The Thais...

Finally, a Major Pharma Company from China?

Posted by: Bruce Einhorn on January 07

Chinese companies like Lenovo in computers and Huawei in telecom equipment are building their brands worldwide, but when it comes to the pharma industry, the Chinese are anonymous. The country’s...

Indian Pharma Investors Shrug Off Latest Lawsuit

Posted by: Bruce Einhorn on December 12

Barely a month goes by without news of a big multinational drugmaker suing an upstart Indian rival company for patent infringement. Big Pharma companies worried about threats from generics makers...

Burma, an investment destination?

Posted by: Bruce Einhorn on October 10

Leave it to the People’s Daily to find some upbeat news from Burma. Yes, the junta may be killing monks and crushing dissent. But according to the official newspaper of...

China throws money at its drug scandals

Posted by: Bruce Einhorn on August 13

Now that the Chinese government has executed the former top food and drug regulator, Beijing wants to show the rest of the world that we don’t need to worry so...

Who wins from Novartis's India loss

Posted by: Bruce Einhorn on August 09

When it comes to counterfeiting, piracy, fakery and overall disdain for intellectual property rights, few countries can match China. So when a pharmaceutical executive says that the patent-protection situation in...

AstraZeneca: Never mind China's scandals

Posted by: Bruce Einhorn on July 03

European pharma company AstraZeneca has chosen an odd time to announce a new China initiative. The headlines these days are full of scare stories about dangerous made-in-China products. If you’re...

Chinese competition hurting Indian drugmakers

Posted by: Bruce Einhorn on December 12

You might think that India’s pharmaceutical industry would be one business where locals needn’t fret too much about competition from China. While China has no big-name drugmakers with significant presence...

Can soaring population give India an edge over China?

Posted by: Bruce Einhorn on September 19

India’s population is exploding and is likely to surpass China as the world’s biggest within a few decades. In a country where more than 25% of the people live in...

A big pharma deal for India

Posted by: Bruce Einhorn on August 28

Further confirmation that India is becoming a key player in the global pharmaceutical industry: American generic drugmaker Mylan Laboratories today announced a deal worth up to $736 million to acquire...

Is China's drug industry really better than India's?

Posted by: Bruce Einhorn on August 07

Sorry to pile on, but there’s another report out questioning the ability of India to compete against China. Bain & Co. has released a survey of pharmaceutical executives that concludes...


Bloomberg Businessweek’s team of Asia reporters brings you the latest insights on business, politics, technology and culture from some of the world’s biggest and fastest-growing economies.

BW Mall - Sponsored Links

Buy a link now!